Studies

  1. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease

  2. Isolation of *Mycobacterium avium* Subspecies *paratuberculosis* Reactive CD4 T Cells from Intestinal Biopsies of Crohn’s Disease Patients

  3. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease

  4. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn’s disease

  5. Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray

  6. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

  7. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

  8. The treatment-naive microbiome in new-onset Crohn’s disease

  9. A decrease of the butyrate-producing species *Roseburia hominis* and *Faecalibacterium prausnitzii* defines dysbiosis in patients with ulcerative colitis

  10. Bacterial protein signals are associated with Crohn’s disease